IL249686A0 - Biological characterization of a glatiramer acetate related drug product using mammalian and human cells - Google Patents
Biological characterization of a glatiramer acetate related drug product using mammalian and human cellsInfo
- Publication number
- IL249686A0 IL249686A0 IL249686A IL24968616A IL249686A0 IL 249686 A0 IL249686 A0 IL 249686A0 IL 249686 A IL249686 A IL 249686A IL 24968616 A IL24968616 A IL 24968616A IL 249686 A0 IL249686 A0 IL 249686A0
- Authority
- IL
- Israel
- Prior art keywords
- mammalian
- human cells
- drug product
- glatiramer acetate
- related drug
- Prior art date
Links
- 108010072051 Glatiramer Acetate Proteins 0.000 title 1
- FHEAIOHRHQGZPC-KIWGSFCNSA-N acetic acid;(2s)-2-amino-3-(4-hydroxyphenyl)propanoic acid;(2s)-2-aminopentanedioic acid;(2s)-2-aminopropanoic acid;(2s)-2,6-diaminohexanoic acid Chemical compound CC(O)=O.C[C@H](N)C(O)=O.NCCCC[C@H](N)C(O)=O.OC(=O)[C@@H](N)CCC(O)=O.OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 FHEAIOHRHQGZPC-KIWGSFCNSA-N 0.000 title 1
- 238000012512 characterization method Methods 0.000 title 1
- 229940126534 drug product Drugs 0.000 title 1
- 229960003776 glatiramer acetate Drugs 0.000 title 1
- 210000005260 human cell Anatomy 0.000 title 1
- 210000004962 mammalian cell Anatomy 0.000 title 1
- 239000000825 pharmaceutical preparation Substances 0.000 title 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
- G01N33/5023—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects on expression patterns
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Hematology (AREA)
- Chemical & Material Sciences (AREA)
- Urology & Nephrology (AREA)
- Molecular Biology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Toxicology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Food Science & Technology (AREA)
- Cell Biology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (8)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462019857P | 2014-07-01 | 2014-07-01 | |
| US201462020358P | 2014-07-02 | 2014-07-02 | |
| US201462025953P | 2014-07-17 | 2014-07-17 | |
| US201462047437P | 2014-09-08 | 2014-09-08 | |
| US201462078369P | 2014-11-11 | 2014-11-11 | |
| US201562134245P | 2015-03-17 | 2015-03-17 | |
| US201562162308P | 2015-05-15 | 2015-05-15 | |
| PCT/US2015/038901 WO2016004250A2 (en) | 2014-07-01 | 2015-07-01 | Biological characterization of a glatiramer acetate related drug product using mammalian and human cells |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL249686A0 true IL249686A0 (en) | 2017-02-28 |
Family
ID=55020098
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL249686A IL249686A0 (en) | 2014-07-01 | 2016-12-21 | Biological characterization of a glatiramer acetate related drug product using mammalian and human cells |
Country Status (6)
| Country | Link |
|---|---|
| EP (1) | EP3164710A4 (en) |
| CA (1) | CA2952849A1 (en) |
| IL (1) | IL249686A0 (en) |
| TW (1) | TW201610169A (en) |
| UY (1) | UY36197A (en) |
| WO (1) | WO2016004250A2 (en) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MA45496A (en) * | 2016-06-17 | 2019-04-24 | Hoffmann La Roche | NUCLEIC ACID MOLECULES FOR PADD5 OR PAD7 MRNA REDUCTION FOR TREATMENT OF HEPATITIS B INFECTION |
| WO2018053109A1 (en) * | 2016-09-14 | 2018-03-22 | Teva Pharmaceutical Industries Ltd. | Gene expression characterization of a glatiramer acetate related drug product in mammalian and human cells |
| PE20200868A1 (en) | 2017-10-16 | 2020-08-31 | Hoffmann La Roche | Antisense oligonucleotides and conjugates comprising them for the reduction of PAPD5 and PAPD7 mRNA |
| CN116637123B (en) * | 2023-06-07 | 2024-02-13 | 上海市东方医院（同济大学附属东方医院） | Application of reagents for knocking down or down-regulating C15orf39 gene expression in the preparation of drugs for the treatment of gastric cancer |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2381254B2 (en) * | 2007-06-21 | 2017-07-19 | Momenta Pharmaceuticals, Inc. | Copolymer assay |
-
2015
- 2015-06-24 TW TW104120408A patent/TW201610169A/en unknown
- 2015-06-29 UY UY0001036197A patent/UY36197A/en not_active Application Discontinuation
- 2015-07-01 CA CA2952849A patent/CA2952849A1/en not_active Abandoned
- 2015-07-01 EP EP15814349.5A patent/EP3164710A4/en not_active Withdrawn
- 2015-07-01 WO PCT/US2015/038901 patent/WO2016004250A2/en not_active Ceased
-
2016
- 2016-12-21 IL IL249686A patent/IL249686A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2016004250A2 (en) | 2016-01-07 |
| TW201610169A (en) | 2016-03-16 |
| WO2016004250A3 (en) | 2016-03-17 |
| UY36197A (en) | 2016-01-29 |
| EP3164710A2 (en) | 2017-05-10 |
| CA2952849A1 (en) | 2016-01-07 |
| EP3164710A4 (en) | 2018-04-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL279001A (en) | Nasal drug products and methods of their use | |
| EP3204113A4 (en) | Methods and apparatus for stimulation of biological tissue | |
| IL249189A0 (en) | Combination therapy of antibodies activating human cd40 and antibodies against human pd-l1 | |
| SG11201700292WA (en) | Biological tissue adhesive composition and method of preparation thereof | |
| EP3039624A4 (en) | Merchandise activity sensor system and methods of using same | |
| EP3183026A4 (en) | Implants for localized drug delivery and methods of use thereof | |
| EP3149025A4 (en) | Cell penetrating peptides and methods of making and using thereof | |
| EP3212221A4 (en) | Efficient delivery of therapeutic molecules in vitro and in vivo | |
| EP3202305A4 (en) | Disposable endoscope and system | |
| SG11201701444RA (en) | Methods for the production and use of mycelial liquid tissue culture | |
| EP3167046A4 (en) | Manufacture and cryopreservation of fucosylated cells for therapeutic use | |
| EP3234107A4 (en) | B cells for in vivo delivery of therapeutic agents | |
| EP3160234A4 (en) | Antimicrobial-antibiofilm compositions and methods of use thereof for personal care products | |
| EP3209251A4 (en) | Platinum-catalyzed silicone drug delivery devices and methods of use thereof | |
| EP3123176A4 (en) | Diagnosis of multiple sclerosis in human and animal subjects | |
| EP3186354A4 (en) | Modular single-use kits and methods for preparation of biological material | |
| FR3021318B1 (en) | 20-HYDROXYECDYSONE-DERIVED PRODUCTS AND THEIR USE IN THE PREPARATION OF MEDICAMENTS | |
| EP3236992A4 (en) | Peptides and their use in the treatment of skin | |
| ZA201703833B (en) | Oral care products and methods of use and manufacture thereof | |
| PL3132020T3 (en) | Vessel for cell culture and use thereof | |
| IL249686A0 (en) | Biological characterization of a glatiramer acetate related drug product using mammalian and human cells | |
| EP3167043A4 (en) | Bioreactor for production and harvesting of microalgae | |
| GB201500500D0 (en) | Biological materials and therapeutic uses thereof | |
| ZA201607466B (en) | Therapeutic use of grape seed products | |
| EP3233075A4 (en) | Use of ellagic acid dihydrate in food products and nutraceuticals |